QA: Dynavax Technologies CORP in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2013_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 128,187,000
1 IntangibleAssetsNetIncludingGoodwill 2,475,000
2 PropertyPlantAndEquipmentNet 7,965,000
3 remainder_Assets 1,125,000
4 LiabilitiesCurrent 19,014,000
5 LiabilitiesNoncurrent 629,000
6 remainder_Liabilities 5,283,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,164,000
9 ResearchAndDevelopmentExpense 49,146,000
10 remainder_Expenses 2,351,000
11 remainder_Revenues 9,714,000
12 remainder_NetIncome -2,000
13 remainder_ComprehensiveNetIncome 414,000
  yvar yval
0 Assets 139,752,000
1 Liabilities 24,926,000
2 Expenses 79,661,000
3 Revenues 9,714,000
4 StockholdersEquity 114,826,000
5 NetIncome -69,949,000
6 ComprehensiveNetIncome -69,742,000
7 BaseVar 127,234,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.19
9 EconomicCapitalRatio 3.15

Edgar->Model Mapping

Feature Distribution

Change over Time